James Kelley, MD, PhD

James Kelley, MD, PhD has an extensive work experience spanning multiple prestigious medical institutions. Starting in 2005, they served as a Postdoctoral Fellow at the University of Alabama at Birmingham until 2010. Following this, they completed their residency as a Resident Physician at Brigham and Women's Hospital from 2010 to 2013. Concurrently, they also held positions as a Clinical Fellow at Harvard Medical School from 2010 to 2014 and as a Postdoctoral Researcher at Boston Children's Hospital from 2012 to 2013.

In 2014, Dr. Kelley joined MD Anderson Cancer Center as an Assistant Professor and Director of Laboratory Medicine. Their responsibilities included being a Transfusion Medicine Physician, a Patient Safety & Quality Officer, and a CLIA Laboratory Director overseeing clinical laboratories conducting over 14 million tests annually. Notably, they designed and implemented a real-time hemovigilance platform utilizing a human-machine hybrid and artificial intelligence. James also served as a Site Principal Investigator for various industry-sponsored clinical trials and coordinated efforts for compliance with CMS, CAP, and AABB regulations and standards.

From 2013 to 2014, Dr. Kelley worked as a Clinical Fellow at Massachusetts General Hospital. Additionally, they held the role of Chief Medical Officer at OneOme since July 2022 and previously served as the Director at Terumo Blood and Cell Technologies from May 2020 to July 2022.

James Kelley, MD, PhD has an extensive education history. James began their academic career at Samford University, where they earned a Bachelor of Science degree in Biology, General in the years 1998 to 2002. Following this, they pursued a Doctor of Philosophy - PhD in Immunology at the University of Cambridge from 2002 to 2005.

Subsequently, Kelley attended the University of Alabama at Birmingham from 2006 to 2010 and obtained a Doctor of Medicine - MD, specializing in Medicine. In their quest for further knowledge, they enrolled at The Johns Hopkins University - Carey Business School from 2019 to 2022 to pursue a Master's of Science in Health Care Management.

In addition to their extensive educational background, Kelley has obtained various certifications to enhance their professional capabilities. James has been certified as a Physician by the Medical Practice, Minnesota Board of obtaining the license in October 2022. In September 2020, they obtained the Colorado Physician Medical Doctor certification from the Colorado Department of Regulatory Agencies. Furthermore, Kelley acquired certifications in Clinical Informatics from The American Board of Pathology (ABPath) in November 2019, and in Regulatory Affairs from the Regulatory Affairs Professionals Society (RAPS) in June 2018.

Kelley has also achieved certifications from the College of American Pathologists (CAP) as a Laboratory Medical Director in June 2016, and from the Texas Medical Board as a Full Physician License in April 2014. Their expertise includes Blood Banking/Transfusion Medicine, certified by The American Board of Pathology in September 2015, and Clinical Pathology, certified by The American Board of Pathology in May 2014. Additionally, they hold certifications in Medical Quality and Lean Six Sigma Black Belt - Healthcare, obtained from the American Board of Medical Quality in May 2017, and Villanova University, respectively. Finally, Kelley has been certified as a Certified Manager of Quality/Organizational Excellence by ASQ - World Headquarters in September 2017.

Given the information provided, it is evident that James Kelley, MD, PhD has pursued extensive education and acquired numerous certifications, allowing him to contribute to the medical and healthcare fields in various capacities.